Elanco Animal Health Inc

ELAN Biotech & pharma

Develops antibiotics and parasite preventatives for farm and pet animals.

Jun 2026Revenue $5.02B/yrExpenses $5.19B/yr
No trend
Figures by year

When will Elanco Animal Health be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $5.02B and expenses $5.19B.

Fiscal year toRevenueExpensesPre-tax profit
Dec 2025$4.71B$4.94B−$224M
Dec 2024$4.44B$3.95B$488M
Dec 2023$4.42B$5.61B−$1.20B
Dec 2022$4.41B$4.48B−$72.0M
Dec 2021$4.76B$5.33B−$571M
Dec 2020$3.27B$3.95B−$677M
Dec 2019$3.07B$2.99B$78.0M
Dec 2018$3.07B$2.95B$114M
Dec 2017$2.89B$3.12B−$233M
Dec 2016$2.91B$2.94B−$22.4M